Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Monetizing Minors: Piper Rockelle
A calorie-counting app is just one of the adult products promoted on this minor’s social media channels.
Playful Rewards
This app may play games with your money.
CATrends: Deceptive Influencer Marketing
It’s a hot sponcon summer.
Enterprise Rent-A-Car
What’s this reservation good for?
Prevagen May Have Memory Problems
TINA.org continues to support FTC, New York in federal court.